BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31636360)

  • 1. Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells.
    Li L; Mei H; Commey ANA
    Cancer Gene Ther; 2020 Sep; 27(9):691-701. PubMed ID: 31636360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation.
    Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R
    Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
    Makino S; Takahashi H; Okuzaki D; Miyoshi N; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Mizushima T; Mori M; Doki Y
    Carcinogenesis; 2020 May; 41(3):303-312. PubMed ID: 31562741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
    Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D
    Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c.
    Mohammadi Y; Tavangar SM; Saidijam M; Amini R; Etemadi K; Karimi Dermani F; Najafi R
    Biomed Pharmacother; 2018 Jul; 103():301-307. PubMed ID: 29656186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.
    Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J
    Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
    Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
    Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
    Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
    Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
    Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.
    Güllü N; Kobelt D; Brim H; Rahman S; Timm L; Smith J; Soleimani A; Di Marco S; Bisti S; Ashktorab H; Stein U
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
    Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
    Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
    Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
    Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
    Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.